Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Epeleuton by Afimmune Biopharma for Sickle Cell Disease: Likelihood of Approval
Epeleuton is under clinical development by Afimmune Biopharma and currently in Phase II for Sickle Cell Disease. According to GlobalData,...
Data Insights
Epeleuton by Afimmune Biopharma for Sickle Cell Disease: Likelihood of Approval
Epeleuton is under clinical development by Afimmune Biopharma and currently in Phase II for Sickle Cell Disease. According to GlobalData,...